ON7 TIME-TO-TREATMENT DISCONTINUATION (TTD) AS A PRAGMATIC PREDICTOR OF OVERALL SURVIVAL (OS) IN FIRST-LINE ADVANCED NON-SMALL CELL LUNG CANCER (ANSCLC) - REAL-WORLD PERSPECTIVE

Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.087
https://www.valueinhealthjournal.com/article/S1098-3015(19)32465-9/fulltext
Title : ON7 TIME-TO-TREATMENT DISCONTINUATION (TTD) AS A PRAGMATIC PREDICTOR OF OVERALL SURVIVAL (OS) IN FIRST-LINE ADVANCED NON-SMALL CELL LUNG CANCER (ANSCLC) - REAL-WORLD PERSPECTIVE
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32465-9&doi=10.1016/j.jval.2019.09.087
First page :
Section Title :
Open access? : No
Section Order : 10052
Categories :
Tags :
Regions :
ViH Article Tags :